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Tyrosinase-negative oculocutaneous albinism, the most se-
vere subtype of a heterogeneous group of albinism, is an 
autosomal recessive trait caused by mutations in the tyrosin-
ase gene. Prenatal diagnosis had been made previously only 
by evaluating fetal skin obtained by biopsy, an invasive pro-
cedure that cannot be performed earlier than 19 weeks of 
gestation. A pregnant mother of a 9-year-old Japanese boy 
with tyrosinase-negative oculocutaneous albinism wanted a 
prenatal diagnosis. Polymerase chain reaction amplification 
and allele-specific oligonucleotide hybridization revealed 
that the child is homozygous and the parents heterozygous 
for the pathologic mutation of the tyrosinase gene in exon 2 
O culocutaneous albinism (OCA), an autosomal re-cessive hereditary disorder of melanin metabolism, is characterized by a decrease in melanin in the skin, hair, and eyes [1,2]. Tyrosinase-negative OCA, the most severe subtype of a heterogeneous group, is 
caused by pathologic mutations in the tyrosinase gene [3]. Tyrosin-
ase, a key enzyme for the biosynthesis of melanin in pigment cells, 
catalyzes the conversion of tyrosine to dihydroxyphenylalanine 
(DOPA). Since the first report of a mutation that produces tyrosin-
ase-negative OCA [4], more than 25 alleles, each with a different 
mutation, have been found in patients with OCA [3]. Of these, only 
two major tyrosinase gene mutations have been found in Japanese 
patients [4,5], i.e., a single base insertion in exon 2 that shifts the 
reading frame and introduces a premature termination codon 
(TGA) following amino acid residue 298 (codon 316) [4] and a 
single base mutation in exon 1, causing an arginine to glutamine 
substitution at position 59 {condon 77} [5]. 
Tyrosinase-negative OCA leads to visual disturbances due to 
optic neurologic defects, photosensitivity, and the development of 
various malignant skin tumors [6,7]. The patient may be severely 
handicapped socially, especially in non-Caucasian countries. 
The prenatal diagnosis of OCA had previously been possible only 
by analyzing fetal skin obtained at biopsy. Not only is biopsy of fetal 
skin more invasive than amniocentesis, but it cannot be performed 
earlier than 19 weeks [8,9]. Our objective was to establish a new 
strategy for the prenatal diagnosis of OCA at an earlier stage of 
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(single base insertion) but not for the one in exon 1. Prenatal 
diagnosis was made by analyzing the tyrosinase gene in fetal 
cells obtained by amniocentesis at 14 weeks of gestation, 
which demonstrated that the fetus was heterozygous for mu-
tant tyrosinase gene. Pregnancy wa-s therefore continued and 
a normal male infant was born. 
This procedure, the analysis of the fetal genomic tyrosinase 
DNA, is a rapid and reliable approach to the prenatal diagno-
sis of oculocutaneous albinism at a relatively early stage of 
pregnancy and is safer and less invasive than previous meth-
ods using fetal skin biopsy. Key word: gene analysis. ] Invest 
Dermatol103:104-106,1994 
pregnancy with a less invasive procedure. We present the successful 
prenatal exclusion of tyrosinase-negative OCA by analysis of the 
fetal tyrosinase gene at an early stage of pregnancy. 
MATERIALS AND METHODS 
Electron Microscopic t-3,4-Dihydroxyphenylalanine (DOPA) Re-
action Test The presence of tyrosinase activity was evaluated in a 9-year· 
old Japanese boy with typical clinical features of OCA. His mother was in 
her second pregnancy, and decided to proceed with the pregnancy only if a 
prenatal examination would confirm no evidence of OCA. The boy had 
white hair, light blue eyes, nystagmus, and poor visual acuity. 
The tyrosinase activity of his epidermal melanocytes was evaluated by the 
electron microscopic DOPA reaction test using the skin sample obtained by 
biopsy, as previously described [10]. In brief, the small skin samples were 
fixed with 2% glutaraldehyde and incubated in 0.1 % DOPA/phosphate 
buffer for 4 h at 37' C. The sample was then post fixed in 1 % osmium 
tetroxide for 1 h. After dehydration, the specimen was embedded in Epon. 
Ultrathin sections were cut and investigated in an electron microscopy. As a 
control, we used a sample of skin obtained from a tyrosinase-positive patient 
with OCA who was previously confirmed to show tyrosinase positivity on 
the electron microscopic DOPA reaction test. 
Analysis of Tyrosinase Gene We initially determined whether the 9-
year-old boy with OCA, his parents, and the members of his family pos-
sessed either of the two major pathologic mutations of the tyrosinase gene 
known in Japanese patients with tyrosinase-negative OCA. Blood samples 
were taken from the boy with OCA, as well as his parents, grandmothers, 
grandfathers, three aunts, one uncle, and five cousins. 
DNA was extracted from the peripheral blood by the phenol method and 
amplified by the polymerase chain reaction (PCR). The conditions for peR 
were basically the same as those described previously for exon 1 [5] and exon 
2 [4]. In brief, 868-base pair (bp) and 118-bp sections of the respective 
tyrosinase exons 1 and 2 were amplified using specific primers and Taq 
polymerase (Perkin Elmer Cetus, Norwalk, CT). The synthetic primers 
SP1F (5'-CTGCAGACCTTGTGAGGACT-3') for the sense strand 54 to 
73 and SP2R (5'-GTATATCTAGCATATCTTAC-3') for the antisense 
strand 902 to 921 were used for the partial exon 1 amplification. The 
synthetic primers SP3F (5'-ATTGTCTGTAGCCGATTGGAGG-3') for 
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the sense strand 902 to 923 and SP4R (S'-CTTCCAGTGTATT-
TCTAAAGCT-3') for the antisense strand 1097 to 1118 were also used for 
partial exon 2 amplification. Denaturing, annealing, and polymerizing steps 
were performed at 94·C for 1 min, SO·C for 2 min, and 73·C for 3 min, 
respectively [11]. These steps were repeated for 30 cycles. Subsequently, 10 
pI of the PCR products were dot-blotted onto the same four nylon mem-
branes for the detection of normal or mutant alleles in both exons 1 and 2. 
The products on two membranes were hybridized with either 32P-labeled, 
exon 1-specific normal (ST1N: S'-CCACGACTCCCGGTCATCCA-3') 
or mutant (STIM: S'-CCACGACTCCTGGTCATCCA-3') oligonucleo-
tide probes for the antisense nucleotide sequence 302 to 321 in the presence 
of a fivefold amount of nonlabeled competitive sequences and with gradient 
temperatures from 60·C to 40·C, as described previously [12,13]. The 
other two membranes were also hybridized with either 32P-labeled exon 2-
specific normal (ST2N: S'-GGAGCCTTGGGGTTCTGGAT-3') or mu-
tant (ST2M: S'-GGAGCCTTGGGGGTTCTGGAT-3') oligonucleotide 
probes for the antisense nucleotide sequence of 1000 to 1019, as 
above. 
Prenatal Diagnosis Amniocentesis was performed in the 14th week of 
gestation to obtain fetal cells. Fetal cells were routinely cultured in Falcon 
flasks and maintained in Chang media (Hana Biologicals, Alameda, CAl. At 
confluence on day 7, cells were dislodged mechanically from the flasks using 
a scraper. Genomic fetal DNA was extracted, amplified, and blotted onto the 
nylon membrane as described above. Allele-specific oligonucleotide hybrid-
ization was also performed as above. 
RESULTS 
Electron Microscopic DOPA Reaction Test Electron micro-
scopic DOPA reaction test of the skin sample of the 9-year-old boy 
with OCA demonstrated only melanosomes of stage I and II, even 
after incubation in the DOPA solution, and there was no further 
melanization of the premature melanosomes in melanocytes (Fig 
lA). Stage II melanosomes were oval and measured about 300 nm 
long and 100 nm wide. They often presented a characteristic matrix 
consisting of parallel longitudinal and transverse filaments (Fig tAl. 
The premature melanosomes in the skin of two control Japanese 
patients with tyrosinase-positive OCA were clearly melanized to 
stage IV following incubation in DOPA solution (Fig IB). These 
results confirmed the lack of tyrosinase activity in the melanocytes 
of this 9-year-old boy. 
Analysis of Tyrosinase Gene No nucleotide mutation was 
found in exon 1 in the DNA of the 9-year-old boy with tyrosinase-
negative OCA or in any members of his family, including the par-
ents and the 12 other relatives examined (Fig 2). Thus the normal, 
but not the mutant, probe hybridized with the amplified DNA of all 
the family members. The mutant probe for exon 2 hybridized with 
the amplified DNA of the patient and his parents, grandmothers, 
three aunts, and one cousin, but not with that of his grandfathers, 
one uncle, and two cousins. The normal probe for exon 2 hybridized 
with the amplified DNA of all samples except that from the pro-
band (Fig 2). 
These data confirm the autosomal recessive inheritance of OCA 
in the family pedigree. The data also indicate that the patient's 
tyrosinase gene indeed contained an insertion of a C residue in both 
alleles, resulting in a homozygous condition for the mutant tyrosin-
ase gene. His parents, grandmothers, and several relatives, but not 
his grandfathers, were confirmed to be heterozygous and thus were 
expected to be carriers of the OCA trait. 
Prenatal Diagnosis Based on data from the tyrosinase gene mu-
tation of the patient and his family members, prenatal diagnosis was 
performed using DNA extracted from the fetal cells obtained by 
amniocentesis. No nucleotide mutation was found on exon 1 in the 
fetal DNA (number 16 of Fig 2) . Amplified fetal DNA hybridized 
with both mutant and normal probes for exon 2 of the tyrosinase 
gene, confirming that the. fetus was not homozygously affected but 
was a heterozygous carrier of OCA. Pregnancy was therefore con-
tinued and a normal male infant was delivered. He had black hair 
and eyes and no evidence of OCA. 
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DISCUSSION 
Our results confi.rm that the analysis of the tyrosinase gene by PCR 
amplification and allele-specific oligonucleotide hybridization en-
ables prenatal diagnosis of tyrosinase-negative OCA. This can be 
done at a relatively early stage of pregnancy, as early as 8-10 weeks 
of gestation by chorionic villus sampling, or at 12-14 weeks of 
gestation by amniocentesis. In the present case, when we could 
confirm the mutation in exon 2 of the tyrosinase gene in this family, 
the mother was already in her 14th week of pregnancy. We there-
fore obtained feta l cells by amniocentesis, the safest option at this 
stage of pregnancy. This technique also provided a quick and reli-
able diagnosis of the patients and carriers with simple blood sam-
pling. 
The prevalence of OCA in Japan is about 1 in 20,000 people. 
Once the non-Caucasian parents have an albino child, they usually 
do not wish to continue the pregnancy with an affected fetus. In 
fact, the parents of this 9-year-old boy with OCA, like other parents 
in our experience [14], had decided to discontinue the pregnancy if a 
prenatal diagnosis could not be obtained. 
The first prenatal diagnosis of OCA was made in 1983, in which a 
lack of stage IV melanosomes in hair bulb melanocytes of the fetal 
scalp obtained at 20 weeks gestation was confirmed by electron 
microscopic observation [15]. The technical difficulty of this 
method is that the skin must be taken from the scalp of the fetus; 
hair bulb melanocytes must be located by serially sectioning small 
samples of skin [16]. To overcome this technical problem, we re-
cently introduced an electron microscopic DOPA reaction test that 
Figure 1. Electron micrographs of the epidermal melanocyte of the skin 
sample incubated with DOPA solution. A) Melanocytes of the 9-year-old 
boy with OCA contain only stage I and II mclanosomes even after incuba-
tion with DOPA solution, showing a lack of tyrosinase activity. B) Skin 
sample obtained from a patient with tyrosinase-positive OCA as a control. 
Most premature melanosomes in melanocyte have melanized to stage IV, 
demonstrating the presence of tyrosinase activity. 
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Figure 2. Family pedigree and results of PCR amplification and allele-spe-
cific oligonucleotide hybridization. Individual 13 is the proband, a 9-year-
old boy with tyrosinase-negative OCA. Number 16 is the fetus examined for 
the prenatal diagnosis, and 17 is a normal healthy adult serving as a conttol. 
No nucleotide mutation was found in exon 1 of the tyrosinase gene in any 
family member including the proband. The normal probe (N) for exon 1 but 
not the mutant probe (M) thus hybridized to all the samples examined (not 
all data shown). The mutant probe (M) for exon 2 hybridized with the 
amplified DNA of the proband (individual 13), his parents (4 and 10), his 
grandmothers (2 and 9), his three aunts (5, 11, and 12) and his cousin (15), 
but not with that of his grandfathers (1 and 8), his uncle (3), and his three 
cousins (6, 7, and 14). The normal probe (N) forexon 2 hybridized with the 
amplified DNA of all samples except that from the proband (13). On prena-
tal diagnosis, no nucleotide mutation was found on exon 1 of the fetal 
tyrosinase DNA (16) . Amplified DNA of the fetus (16) hybridized with 
both mutant and normal probes for exon 2 of the tyrosinase gene, confirm-
ing that fetus was not affected with OCA, but was a heterozygous carrier of 
the mutant tyrosinase gene. 
enables easier and more accurate prenatal diagnosis using a specimen 
of fetal skin from any body area [14). However, such methods [14-
16) require fetal skin biopsy, which is invasive and cannot be per-
formed earlier than 19 weeks of gestation. 
Tests for the tyrosinase gene in the boy with OCA and his family 
members confirmed the availability of analysis of the fetal tyrosinase 
gene for prenatal diagnosis. We indeed excluded OCA using amni-
otic cells, not with fetal skin, at 14 weeks of gestation. In the analysis 
of the tyrosinase gene, hybridization was performed under condi-
tions in which the temperature was decreased gradually from 60 · C 
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to 40°C. In this way we could omit the cumbersome procedure of 
determining the proper hybridization temperature for each probe 
and each m embrane [12,13]. Furthermore, by adding an excess 
amount of fivefold competitive sequences in addition to labeled 
oligonucleotides, nonspecific binding could be markedly reduced to 
obtain clear results . Restriction fragment-length polymorphism can 
be a future alternative method for prenatal diagnosis, although fur-
ther study will be necessary. 
In conclusion, analysis of the fetal tyrosinase gene by PCR ampli-
fication and allele-specific oligonucleotide hybridization enables 
the prenatal diagnosis of tyrosinase-negative OCA at an earlier stage 
of gestation. Because only amniocentesis is required, this technique 
is safe and less invasive and can provide a rapid and reliable prenatal 
diagnosis of OCA at an early stage of pregnancy. 
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